Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Huo Guoyong"'
Autor:
Xiang, Zhijun, Zhang, Bingbin, Cao, Shuangyi, Cao, Long, Li, Lingwen, huang, Dehua, Li, Qian, Chen, Yuxiang, Gong, Xuelian, Zhang, Xiaohong, Li, Ruizhi, Wu, Jinmiao, Peng, Yayuan, Huo, Guoyong, Xu, Lixia, Zhang, Zhihui, Li, Di, Xia, Guangxin
Publikováno v:
In International Immunopharmacology 25 October 2024 140
Autor:
Shi, Chen, Wang, Qian, Liao, Xuemei, Ge, Hui, Huo, Guoyong, Zhang, Leduo, Chen, Na, Zhai, Xiong, Hong, Yuan, Wang, Li, Wang, Zhe, Shi, Weijun, Mao, Yu, Yu, Jianxin, Ke, Ying, Xia, Guangxin
Publikováno v:
In European Journal of Medicinal Chemistry 1 May 2020 193
Autor:
Shi, Chen, Wang, Qian, Liao, Xuemei, Ge, Hui, Huo, Guoyong, Zhang, Leduo, Chen, Na, Zhai, Xiong, Hong, Yuan, Wang, Li, Han, Yanan, Xiao, Wenbo, Wang, Zhe, Shi, Weijun, Mao, Yu, Yu, Jianxin, Xia, Guangxin, Liu, Yanjun
Publikováno v:
In European Journal of Medicinal Chemistry 15 September 2019 178:352-364
Autor:
Jianxin Yu, Shi Chen, Huo Guoyong, Na Chen, Li Wang, Xia Guangxin, Liao Xuemei, Liu Yanjun, Zhai Xiong, Xiao Wenbo, Weijun Shi, Mao Yu, Leduo Zhang, Wang Qian, Zhe Wang, Han Yanan, Ge Hui, Yuan Hong
Publikováno v:
European Journal of Medicinal Chemistry. 178:352-364
Targeting CDK4/6 has been identified as an effective therapeutics for treatment of cancer. We herein reported the discovery of a series of 6-(2-(methylamino)ethyl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine derivatives as CDK4/6 inhibitors against c
Autor:
Ge Hui, Leduo Zhang, Jianxin Yu, Shi Chen, Na Chen, Wang Qian, Weijun Shi, Huo Guoyong, Mao Yu, Zhe Wang, Li Wang, Liao Xuemei, Xia Guangxin, Zhai Xiong, Ke Ying, Yuan Hong
Publikováno v:
European journal of medicinal chemistry. 193
CDK4/6 has been identified as an attractive therapeutic target for treatment of cancer. For unmet clinical needs, a novel class of imidazo [1',2':1,6]pyrido [2,3-d]pyrimidin derivatives, which had distinctive triheteroaryl structure, had been discove